AdvanSix (ASIX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for June 18, 2025, to be held virtually, with voting on five key proposals including director elections, auditor ratification, executive compensation, stock incentive plan amendment, and a charter amendment to limit officer liability in line with Delaware law.
Board recommends voting FOR all proposals and director nominees.
Company reported 2024 Adjusted EBITDA of $142 million, Adjusted EPS of $1.96, and positive free cash flow, despite a 1% sales decline and operational disruptions.
Achieved third consecutive EcoVadis Platinum CSR rating and named one of Newsweek's Most Responsible Companies for 2024.
Voting matters and shareholder proposals
Proposal 1: Election of seven directors, with two current directors resigning and the board size reduced.
Proposal 2: Ratification of PricewaterhouseCoopers LLP as independent auditors for 2025.
Proposal 3: Advisory vote to approve executive compensation, with 95% support at the prior annual meeting.
Proposal 4: Approval of amended and restated 2016 Stock Incentive Plan, increasing share reserve and extending plan term.
Proposal 5: Amendment to Certificate of Incorporation to limit liability of certain officers as permitted by Delaware law.
Board of directors and corporate governance
Board reduced to seven members, all with significant leadership, industry, ESG, and financial expertise.
Board leadership structure separates Chair and CEO roles; Chair is independent.
All committees (Audit, Compensation & Leadership Development, Nominating & Governance, Health, Safety & Environmental) are composed entirely of independent directors.
Annual board and committee self-evaluations, with recent improvements to meeting schedules and materials.
Stockholder engagement includes outreach to holders of nearly 70% of shares and annual advisory votes on executive compensation.
Latest events from AdvanSix
- Q4 sales up 9% with Plant Nutrients strength; 2026 focus on cost savings and cash flow.ASIX
Q4 202520 Feb 2026 - Q2 2024 sales and earnings rose on strong nylon, ammonium sulfate, and acetone demand.ASIX
Q2 20242 Feb 2026 - Diversified growth, strong sulfur nutrition demand, and disciplined capital strategy drive outlook.ASIX
CL King’s 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales up 23% to $398M; $12M USDA grant and Hopewell maintenance impact highlighted.ASIX
Q3 202417 Jan 2026 - FY24 net income was $44.1M on $1.52B sales; cash flow and 2025 outlook remain strong.ASIX
Q4 202423 Dec 2025 - Proxy covers director elections, auditor ratification, pay, ESG, and governance reforms.ASIX
Proxy Filing1 Dec 2025 - Board recommends all proxy proposals, including director elections and charter amendment.ASIX
Proxy Filing1 Dec 2025 - Updated voting rules clarify effects of abstentions and non-votes on all annual meeting proposals.ASIX
Proxy Filing1 Dec 2025 - Q1 2025 saw strong sales, profit rebound, and Plant Nutrients growth, aided by insurance proceeds.ASIX
Q1 202528 Nov 2025